Abiopharma

General Announcement: Net Asset Value per unit

Clinical trial NCT07222215: collaborators added: Gateway for Cancer Research, Terri Brodeur Breast Cancer Foundation.

Clinical trial NCT07392892: start date: 2026-04-28 → 2026-05-14.

Clinical trial NCT07501702: start date: 2026-05-01 → 2026-05-13.

Clinical trial NCT07176390 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-09-03 → 2029-03-03 3. primary completion date: 2027-03-08 → 2026-09-05

Clinical trial NCT06549608 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 685 → 683 participants

Clinical trial NCT07582783 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-27 → 2026-05-15 3. completion date: 2028-10-26 → 2028-11-10

Clinical trial NCT06436703: phase: PHASE2 → PHASE1.

BlockchAIn Announces Preliminary Inclusion in Russell Microcap® Index

Gilead - Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief